AMC.L

CRISM Therapeutics Corporation
Amur Minerals Corp - Investor Presentation via Investor Meet Company
15th May 2024, 06:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 4433O
Amur Minerals Corporation
15 May 2024
 

15 May 2024


 

AMUR MINERALS CORPORATION

(AIM: AMC)

 

Investor Presentation via Investor Meet Company

 

Amur Minerals Corporation ("Amur" or the "Company") is pleased to announce that Robin Young, CEO of Amur, and Andrew Webb, CEO of Extruded Pharmaceuticals Limited ("Extruded Pharmaceuticals" or "EPL"), will provide a live presentation on 21 May 2024 at 1pm BST via the Investor Meet Company platform.

 

The presentation will focus on the proposed acquisition of EPL by Amur and all existing and potential shareholders are welcome to participate. Questions can be submitted in advance of the presentation via the Investor Meet Company dashboard up until 20 May 2024 at 9am BST and also at any time during the live presentation.

 

Investors who are not already signed up to Investor Meet Company can sign up here:

https://www.investormeetcompany.com/amur-minerals-corporation/register-investor

 

Investors who already follow Amur on the Investor Meet Company platform will automatically be invited.

 

On the 13 May 2024, Amur announced its intention to acquire EPL, a UK-based drug delivery technology company which is focused on improving the performance of cancer treatments for solid tumours through the local delivery of chemotherapy drugs. The announcement can be viewed here: https://www.londonstockexchange.com/news-article/AMC/proposed-reverse-takeover/16465616

 

The acquisition is subject to a General Meeting of Amur shareholders on 29 May 2024.

 

 

Enquiries:

 

Company

Nomad and Broker

Financial PR

Amur Minerals Corp.

S.P. Angel Corporate Finance LLP

Buchanan

Robin Young CEO

Richard Morrison

Adam Cowl

Mark Court mark.court@buchanancomms.co.uk

Jamie Hooper jamie.hooper@buchanancomms.co.uk

+1 (925) 408-4621

+44 (0) 20 3470 0470

+44 (0) 20 7466 5000

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBIGDULXBDGSS]]>
TwitterFacebookLinkedIn